Reuters reports
that the COVID-19 death toll in China spiked to 1,367 yesterday
compared to 254 the day before with a concomitant jump in confirmed
infections (59,805 vs. 15,152) due to the use of computerized tomography
(CT), a new approach. Previously, infections were confirmed via RNA
tests.
The jump came a day after Chinese authorities
reported the lowest number of new cases in two weeks, bolstering a
forecast by Beijing’s senior medical advisor that the epidemic will end
by April.
Asian stock markets are under pressure while gold and bonds have rallied.
44 new cases have been detected on a Diamond Princess cruise ship quarantined off the coast of Japan.
Hong Kong has extended its suspension of schools until at least March 16.
Selected tickers and premarket moves: Co-Diagnostics (NASDAQ:CODX) (+10%), Novavax (NASDAQ:NVAX) (+4%), NanoViricides (NYSEMKT:NNVC) (+16%), Inovio Pharmaceuticals (NASDAQ:INO) (+11%), Alpha Pro Tech (NYSEMKT:APT) (+12%), Lakeland Industries (NASDAQ:LAKE) (+4%), Gilead Sciences (NASDAQ:GILD) (+0.3%), Regeneron Pharmaceuticals (NASDAQ:REGN) (+2%), Health Care Select Sector SPDR Fund (NYSEARCA:XLV) (-1%), Allied Health Products (NASDAQ:AHPI) (+19%).
More: The stocks that win and lose from coronavirus, and “coronavirus” mentions on companies’ earnings calls.
https://seekingalpha.com/news/3541573-coronavirus-death-toll-jumps-in-china
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.